Platelet-derived growth factor: structural and functional aspects. 1989

B Westermark, and C H Heldin
Department of Pathology, University Hospital, Uppsala, Sweden.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Westermark, and C H Heldin
December 1992, The EMBO journal,
B Westermark, and C H Heldin
December 1991, Current opinion in biotechnology,
B Westermark, and C H Heldin
August 2013, Cold Spring Harbor perspectives in biology,
B Westermark, and C H Heldin
October 2013, Biochimica et biophysica acta,
B Westermark, and C H Heldin
January 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
B Westermark, and C H Heldin
May 1995, Cell biology international,
B Westermark, and C H Heldin
January 1987, Postepy biochemii,
B Westermark, and C H Heldin
May 1989, Lancet (London, England),
B Westermark, and C H Heldin
May 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Copied contents to your clipboard!